- increased circulating LDL cholesterol level / IMPC
- increased erythrocyte cell number / IMPC
- decreased T cell number / IMPC
- decreased CD4-positive, alpha beta T cell number / IMPC
- decreased CD8-positive, alpha-beta T cell number / IMPC
- increased CD4-positive, CD25-positive, alpha-beta regulatory T cell number / IMPC
- increased effector memory CD4-positive, alpha-beta T cell number / IMPC
- decreased alpha-beta T cell number / IMPC
- decreased KLRG1-positive NK cell number / IMPC
C57BL/6N-Etv3em1(IMPC)Wtsi/WtsiOrl
Status | Available to order |
EMMA ID | EM:13703 |
International strain name | C57BL/6N-Etv3em1(IMPC)Wtsi/WtsiOrl |
Alternative name | |
Strain type | Endonuclease-mediated |
Allele/Transgene symbol | Etv3em1(IMPC)Wtsi |
Gene/Transgene symbol | Etv3 |
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
IMPC phenotypes (allele matching)
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).